PGL-135

• CAT Number: I034553
• CAS Number: 26278-83-1
• Molecular Formula: C9H10N2OS
• Molecular Weight: 194.25
• Purity: 98%
• Synonyms: PGL-135; PGL135; PGL 135
• Solubility: To be determined
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 2-amino-4,7-dimethyl-1,3-benzothiazol-6-ol
• InChI: InChI=1S/C9H10N2OS/c1-4-3-6(12)5(2)8-7(4)11-9(10)13-8/h3,12H,1-2H3,(H2,10,11)
• InChIKey: RUTNKAMSWIPHJW-UHFFFAOYSA-N
• SMILES: CC1=CC(=C(C2=C1N=C(S2)N)C)O

PGL-135（Cat No.:I034553）is a small molecule inhibitor studied for its potential use in treating various diseases, particularly cancer. It functions by targeting and inhibiting specific enzymes or proteins involved in cancer cell proliferation, survival, and metastasis. PGL-135 has shown promise in preclinical studies for its ability to disrupt the signaling pathways that drive tumor growth. By interfering with these critical processes, PGL-135 may enhance the effectiveness of other therapies or act as a stand-alone treatment. Ongoing research is focused on evaluating its safety, efficacy, and therapeutic potential in clinical cancer therapy.